Oncology PracticeAntiandrogen therapy improves survival after biochemical recurrence of prostate cancerFebruary 1, 2017Genitourinary Cancer
Oncology PracticeASCO offers practice guidance on small renal massesJanuary 19, 2017Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeAKT inhibition not superior to everolimus for RCCJanuary 10, 2017Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeAdjuvant chemo prolonged survival after radical nephroureterectomyJanuary 9, 2017Genitourinary Cancer
Hospital Physician: Hematology/OncologyCurrent Therapeutic Approaches to Renal Cell CarcinomaJanuary 1, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeFDA affirms bladder cancer warning with diabetes drugDecember 13, 2016Genitourinary Cancer
Oncology PracticeOncolytic virus active against bladder cancerNovember 30, 2016Genitourinary CancerImmunotherapy
Oncology PracticeVaccine/PD-1 inhibitor combo shows early promise against mCRPCNovember 29, 2016Genitourinary CancerImmunotherapy
Oncology PracticeADT not associated with increased risk of dementia in larger studyNovember 21, 2016Genitourinary Cancer
The Journal of Community and Supportive OncologyExpanding treatment options and ongoing challenges for urologic cancersNovember 21, 2016Genitourinary Cancer
The Journal of Community and Supportive OncologyRenal cell carcinoma approval adds another notch to cabozantinib’s beltNovember 21, 2016Genitourinary CancerPatient & Survivor Care
Oncology PracticeCabozantinib bests sunitinib against metastatic RCCNovember 14, 2016Genitourinary CancerRenal Cell Carcinoma
Oncology PracticeTargeting HER1/2 falls flat in bladder cancer trialNovember 4, 2016Genitourinary Cancer
Oncology PracticeCancer survivors report two times greater medication use for anxiety and depressionOctober 26, 2016Patient & Survivor CareMelanomaGynecologic CancerBreast CancerGastroenterologyGenitourinary CancerMixed Topics
